Our Goals
Increase Funding
Trans Ionics moved into a newly renovated laboratory/office complex in the Town Center of The Woodlands in October 2000 and has been
actively doing research since the beginning of 2001. While initial funding for our research was provided by the owners, we have been successful in raising $2 million through Small Business Innovation Research (SBIR) grants primarily from the U. S. Department of Energy.
The highly successful SBIR programs have stimulated technological innovation and increased U.S. competitiveness by allowing small businesses to develop cutting-edge technology to meet Federal research and development needs. Over $2 billion has been allocated for SBIR programs government-wide in 2006 with over $100 million of that expended by DOE.
Strengthen Collaborations
Trans Ionics has established collaborations with a number of companies to advance its technologies. Securing of Phase II SBIR grants, for instance, requires partnership with a company that will aid in the development and commercialization of Federally funded work and helps to ensure that the program is directed in such a way that its value to industry is maximized. See our Partners page for more details.
We have also begun to establish stronger relationships with academic institutions both in Texas and outside of the state. We view these relationships as key to our success.
Investor Info
Plan for the Future
Trans Ionics has a number of novel technologies in various stages of commercial readiness. It is our plan to begin commercializing one of these every 12-18 months beginning in 2007. In order to accomplish this, we will need to raise additional funds and plan to do so beginning in January 2007. A second offering is possible within three years to raise the capital necessary to begin commercialization of the more capital-intensive Ion Transport Membrane (ITM) based technologies like SeprOx and TransFining-R.
Key to this growth is our location in The Woodlands, TX, the fastest growing business center in the Greater Houston area and an ideal place to both nurture a small business and attract quality employees. Its Research Forest is home to a growing number of biotechnology
companies like Lexicon Genetics; and its Town Center is home to such energy related companies as Shell, Anadarko, Chicago Bridge & Iron, Hughes-Christiansen, GE, and Chevron-Phillips. We expect to continue to make The Woodlands our corporate headquarters and site of our first
manufacturing facility.
Disclaimer/Cautionary Statement
Trans Ionics Corporation can give no assurance that the information contained on our website or any of our linked sites is current, accurate or complete.
Any decision made by you based on information contained on our website is your responsibility. We shall not be liable for damages of any kind arising
out of your access or inability to access our website or your reliance on the information on our website.
No information on our website or any of our linked sites shall constitute a solicitation to invest in Trans Ionics Corporation or any affiliate.
Certain of the statements contained on our website may be statements of future expectations and other forward-looking statements that are based on
Trans Ionics Corporation’s management’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual
results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-
looking by reason of context, the words “may,” “will,” “should,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” or “potential”
and similar expressions identify forward-looking statements. We assume no obligation to update any forward-looking information contained on our
website.